Behaviour of free radicals in Alzheimer's disease;Comportamento dei radicali liberi nella malattia di Alzheimer

Minerva Medica

Volumn 92, Issue 6, 2001, Pages 405-410

  Terranova, R ^a   Sorace, R ^a   Romeo, A ^a   Di Mauro, C ^a   Romeo, R ^a   Luca, S ^a  

^a Ospedale PO Garibaldi   (Italy)

Author keywords

Alzheimer disease, physiology; Antioxidants; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CYSTEINE; FLAVONOID; FREE RADICAL; RETINOL; SELENIUM; UBIDECARENONE; VITAMIN B GROUP; ZINC;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; QUESTIONNAIRE; SLOW BRAIN WAVE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; FREE RADICALS; HUMANS; MALE; OXIDATIVE STRESS;

EID: 0035719121     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Free radicals in Alzheimer's disease
2. Possible causes of Alzheimer's disease: Amyloid fragments, free radicals, and calcium homeostasis
3. Free radical damage, iron, and Alzheimer's disease
4. Current status of antioxidant therapy for Alzheimer's disease
5. Alzheimer's disease
6. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
7. Wide range in age of onset for chromosome 1 type familial Alzheimer disease
8. Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant
9. 42 in neocortical and cerebrovascular amyloid β deposits in Swedish familial Alzheimer's disease and Down's syndrome
10. Alzheimer's disease: Genotypes, phenotypes, and treatment
11. Alzheimer's disease and soluble Aβ
12. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
13. Clinical and neurophatological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology
14. Missense mutations associated with familial Alzheimer's disease in Sweden lead to the production of the amyloid peptide without internalization of its precursor
15. Amyloid beta amyloidosis in Alzheimer's disease
16. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation
17. β-amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: Implications for Alzheimer's disease
18. Hydrogen peroxide mediates amyloid β protein toxicity
19. Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons
20. 2 generation
21. The antioxidant enzymatic blood profile in Alzheimer's and vascular disease. Their association and a possible assay to differentiate dementes subjects and controls
22. Freeradicals in Alzheimer's dementia: Currently available therapeutic strategies
23. Ageing: A theory based on free radicals and radiation chemistry
24. Selective accumulation of aluminium and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study
25. Evidence of neuronal oxidative damage in Alzheimer's disease
26. A mechanism for the stimulatory effect of aluminium on iron-induced lipid peroxidation
27. Mechanisms of neurotoxicity associated with amyloid β depositino and the role of free radicals in the pathogenesis of Alzheimer's disease. A critical appraisal
28. Widespread peroxynitrite-mediated damage in Alzheimer's disease
29. Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxigen
30. Induction of Alzheimer's antigens by an uncoupler of oxidative phosphorylation
31. α-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. A critical appraisal
32. Radical AGEing in Alzheimer's disease
33. Carbonyl-related post-translational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease
34. Iron accumulation in Alzheimer disease is a source of redox-generated free-radicals
35. I radicali liberi mediano il danno cellulare nella malattia di Alzheimer
36. Invecchiamento e radicali liberi
37. Effect of age and caloric rescriction on DNA oxidative damage in different tissue of C 57BL/6 mice
38. Age related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain
39. Cytochrome oxidase deficiency in Alzheimer's disease
40. Mitochondrial function in brain tissue in primary degenerative dementia
41. Bioenergetic and oxidative stress in neurodegenerative disease
42. Protein damage and degradation by oxigen radicals. General aspects
43. Reactive oxygen metabolites and reperfusion injury: Aberrant triggering of reticuloendothelial function
44. A simple test to monitor oxidative stress
45. Mini mental State. A practical method for grading the cognitive state of patients for the clinician
46. A new rating scale for Alzheimer's disease
47. The ten-twenty system of the International Federation Electroencephalogr
48. Studio dei potenziali evocati lenti uditivi nella malattia di Alzheimer
49. Electroencephalography as a diagnostic tool in dementia
50. Quantitative EEG in patients with pre-senile and senile dementia of the Alzheimer type
51. Quantitative EEG analysis in early onset Alzheimer's disease: A controlled study
52. Analisi spettrale dei segnali EEG nella malattia di Alzheimer
53. Ubiquitin is a component of paired helical filaments in Alzheimer's disease
54. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains
55. Oxidative damage in Alzheimer's
56. Early AGEing and Alzheimer's
57. Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease
58. Electrophysiological effects of 25-35 amyloid-β-protein on guinea pig lateral septal neurons
59. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
60. Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides
61. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship
62. The epidemiology of estrogen replacement therapy and Alzheimer's disease
63. Proof of efficacy of ginkgo biloba special extract Egb 761 in outpatients suffering from mild to moderate primary degenerative dementiam of the Alzheimer type or multi-infarct dementia
64. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta amyloid peptide
65. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease